⌘K
Loading ticker…
As of 2026-08-24, PMV Pharmaceuticals, Inc (PMVP) has a 3-month relative strength percentile of 55 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.6%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
PMVP appears in 1 ETF as of May 2026: AVTM at 0.00% weight, $6K notional.
Held by 4 ETFs · $3M across latest filings · largest weight 0.02% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVTM | 0.00% | $6K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PMVP Jan avg: -17.13% median: -9.78% win: 0% σ: 17.77% n: 4 2022-04-12 → 2026-07-31 | PMVP Feb avg: 11.73% median: 0.80% win: 50% σ: 31.25% n: 4 2022-04-12 → 2026-07-31 | PMVP Mar avg: -22.36% median: -23.75% win: 0% σ: 10.96% n: 4 2022-04-12 → 2026-07-31 | PMVP Apr avg: -4.72% median: -3.35% win: 40% σ: 15.88% n: 5 2022-04-12 → 2026-07-31 | PMVP May avg: -5.33% median: -11.29% win: 40% σ: 14.02% n: 5 2022-04-12 → 2026-07-31 | PMVP Jun avg: 11.91% median: 17.01% win: 80% σ: 13.36% n: 5 2022-04-12 → 2026-07-31 | PMVP Jul avg: 5.73% median: 4.47% win: 80% σ: 18.26% n: 5 2022-04-12 → 2026-07-31 | PMVP Aug avg: -0.83% median: -3.42% win: 25% σ: 7.84% n: 4 2022-04-12 → 2026-07-31 (current) | PMVP Sep avg: -8.64% median: -9.80% win: 0% σ: 7.34% n: 4 2022-04-12 → 2026-07-31 | PMVP Oct avg: -15.46% median: 2.08% win: 75% σ: 40.13% n: 4 2022-04-12 → 2026-07-31 | PMVP Nov avg: 6.43% median: -3.50% win: 25% σ: 31.10% n: 4 2022-04-12 → 2026-07-31 | PMVP Dec avg: 2.61% median: -6.05% win: 25% σ: 22.08% n: 4 2022-04-12 → 2026-07-31 |